Abstract
Life Sciences Funding in Europe (2007) analyses the public, private and charity funding scenario in European Countries. Analysis of the Framework Programme 7 and other funding organisations in Europe has been provided. The countries included in the analysis are the United Kingdom, Germany, France, Italy and Spain. Challenges faced by the European R&D funding system and the efforts taken by the countries to tackle these problems have been analysed.
Table of Contents
1 EXECUTIVE SUMMARY
- Overview of the Life Sciences Funding in Europe
- Executive Summary of the Life Sciences Funding in Europe
2 GLOSSARY
- Glossary of Terms
- Terminologies
- Key Acronyms
- Acronyms
3 ASSUMPTIONS AND METHODOLOGY
- Research Scope and Methodology
- Research Scope and Segmentation
4 FUNDING IN EUROPE
- Funding Landscape
- Funding Scenario
- European Funding Overview
- European Funding Challenges
- Market Engineering Measurements
- Funding Analysis
5 FUNDING IN THE UNITED KINGDOM
- Funding Overview
- Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
- Funding Analysis
6 FUNDING IN GERMANY
- Funding Overview
- Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
- Funding Analysis
7 FUNDING IN FRANCE
- Funding Overview
- Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
- Funding Analysis
8 FUNDING IN ITALY
- Funding Overview
- Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
- Funding Analysis
9 FUNDING IN SPAIN
- Funding Overview
- Overview
- Market Engineering Measurements
- Market Engineering Research
- Funding Scenario
- Funding Analysis
10 DECISION SUPPORT DATABASE
- Database Tables
- Biotech Companies
- Biotech Private Investment
- Per cent of Government Investment in Biotechnology
- Government Biotech R&D Investment
- Enrollment of Students
